Results 151 to 160 of about 2,055,307 (265)

Sustainable logistics development strategy based on SWOT and analytic hierarchy process. [PDF]

PLoS One
Xiao C.
europepmc   +1 more source

The Development Strategy of Home-Based Exercise in China Based on the SWOT-AHP Model. [PDF]

Int J Environ Res Public Health, 2021
Li H, Chen X, Fang Y.
europepmc   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

New Horizon in Clinical Development Strategy in Japan Based on New Guideline on Japanese Phase 1 Studies Prior to Multi-Regional Clinical Trials. [PDF]

Clin Transl Sci
Fukuhara K, Shimizu T, Yamamoto J, Tsuda Y, Kobayashi Y, Nagai N, Oikawa J.   +6 more
europepmc   +1 more source

Promotion to Top-Tier Journal and Development Strategy of the Annals of Laboratory Medicine for Strengthening its Leadership in the Medical Laboratory Technology Category: A Bibliometric Study. [PDF]

Ann Lab Med, 2022
Huh S.
europepmc   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Phybrata Digital Biomarkers of Age-Related Balance Impairments, Sensory Reweighting, and Intrinsic Fall Risk

Medical Devices: Evidence and Research
John D Ralston,1 Scott Stanley,2 Joshua M Roper,1 Andreas B Ralston3 1Neursantys Inc., Menlo Park, CA, 94025, USA; 2Caring Hands Caregivers, Cupertino, CA, 95014, USA; 3Vizient Inc., Chicago, IL, 60607, USACorrespondence: John D Ralston, Email john ...
Ralston JD, Stanley S, Roper JM, Ralston AB   +3 more
doaj  

Building a baby-friendly community: Development, strategy, implementation and evaluation of a BFCI program. [PDF]

J Adv Nurs
Lok KYW, Fan HSL, Ip HL, Leung ETY, Lau KW, Wong JYH, Choi E, Lam CCO, Tarrant M, Ngan HYS, Ip P, Lin CC.   +11 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Revisiting development strategy under climate uncertainty: case study of Malawi. [PDF]

Clim Change
Mukashov A, Thomas T, Thurlow J.
europepmc   +1 more source